Head, US Commercial Patient Advocacy & Ecosystem Strategy

Head, US Commercial Patient Advocacy & Ecosystem Strategy

Location:

Washington, DC

The US healthcare system is complex and constantly evolving. GSK collaborates with diverse stakeholders to better understand patient needs in diagnosis, treatment, delivery, and care.

Our ambition is to collaborate with external groups (health organizations, public health societies, patient advocacy groups, and non-traditional partners) to address specific challenges and opportunities in
1) prioritized disease areas,
2) US health system changes and broader policy reforms,
3) external giving opportunities aligned with GSK priorities.

The Head, US Commercial Patient Advocacy & Ecosystem Strategy (PAES) will report to the Vice President, US Government Affairs and Public Policy & Advocacy (GAPPA). This person will serve as a key member of the GAPPA LT, responsible for leading targeted engagement with patient groups in priority disease areas and driving advocacy for system‑level changes to shape the policy and access environment (both local and national) related to GSK’s product portfolio.

The Head, PAES manages a team accountable for driving external GSK advocacy and health system initiatives, managing relationships with external groups and organizations, as well as external funding strategies. The incumbent will work with stakeholders in a highly matrixed environment. These partners include the US Commercial Leadership Team, US Business Unit Heads and Functional Vice Presidents, the GAPPA Leadership Team, US Medical Affairs and the Chief Patient Organization, global Patient Advocacy & Engagement, the Strategy/Insights/Analytics Team, Digital & Technology, national PAG (Patient Advocacy Groups) and public health group leaders.

With a focus on GSK’s priorities, the Head will transform how GSK serves patients, providers, and ultimately brings value to the US healthcare system.

• Implement the vision of the team to establish GSK leadership in both disease advocacy/awareness and proactively shaping the broader environment
• Lead prioritized external stakeholder engagements in priority disease and issue areas
• Ensure advocacy partnerships improve the care experience for patients by addressing barriers to care, closing treatment gaps, and measurably improving the understanding, prevention, and treatment of disease
• Gain key patient and health system insights (access policy, care delivery, reimbursement, technology, innovation) from external collaboration; embed and represent key findings in GSK strategies through appropriate internal teams (IBCT, Market Access, SITO, Digital & Tech)
• Integrate US health system trends in diagnosis, treatment, and delivery to proactively drive specific ecosystem strategies at the local and national levels
• Initiate the "pull through" from advocacy engagements to orchestrate multistakeholder health system initiatives, in collaboration with internal and external partners, to lead advocacy, policy, and ecosystem priorities
• Serve as a strong, forward‑looking thought partner for USC leadership with the ambition to get ahead of US health system transformation
• Act as a strong financial steward of GSK and manage a significant project and external giving budget
• Serve as the single point of accountability for governance, controls, oversight, reporting, and risk management of advocacy activities; ensure funding areas of interest are aligned cross‑functionally and used to guide funding decisions; establish process and risk management/controls for direct contracting with US patients
• Ensure that the team serves as an independent, enterprise‑oriented, product‑agnostic strategic function

• Bachelor’s degree – BA/BS in public policy, public health, health administration, business, communications, political science, or related field.
• At least 8 years in pharma/biotech industry or healthcare consulting
• Deep experience working with external organizations (PAGs, think tanks, etc.) to drive clear health advocacy strategies
• Proven knowledge of US health system design, payment models, delivery transformation (value‑based care, ACOs, integrated delivery systems, AI), and health policy…